Clinical Trial Update: the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of N-acetylcysteine in children with drug-resistant epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Tanta University | Conditions: Drug Resistant Epilepsy | Phase 2 | Status: COMPLETED